Literature DB >> 20418102

The carboxy terminal domain of RNA polymerase II and alternative splicing.

Manuel J Muñoz1, Manuel de la Mata, Alberto R Kornblihtt.   

Abstract

Alternative splicing is controlled by cis-regulatory sequences present in the pre-mRNA and their cognate trans-acting factors, as well as by its coupling to RNA polymerase II (pol II) transcription. A unique feature of this polymerase is the presence of a highly repetitive carboxy terminal domain (CTD), which is subject to multiple regulatory post-translational modifications. CTD phosphorylation events affect the transcriptional properties of pol II and the outcome of co-transcriptional alternative splicing by mediating the effects of splicing factors and by modulating transcription elongation rates. Here, we discuss various examples of involvement of the CTD in alternative splicing regulation as well as the current methodological limitations in deciphering the detailed mechanisms of this process. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20418102     DOI: 10.1016/j.tibs.2010.03.010

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  75 in total

Review 1.  RNA polymerase II elongation control.

Authors:  Qiang Zhou; Tiandao Li; David H Price
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

2.  The RNA polymerase C-terminal domain: a new role in spliceosome assembly.

Authors:  Charles J David; James L Manley
Journal:  Transcription       Date:  2011 Sep-Oct

3.  TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.

Authors:  Marta Montes; Alexandre Cloutier; Noemí Sánchez-Hernández; Laetitia Michelle; Bruno Lemieux; Marco Blanchette; Cristina Hernández-Munain; Benoit Chabot; Carlos Suñé
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

4.  Mediator complex regulates alternative mRNA processing via the MED23 subunit.

Authors:  Yan Huang; Wencheng Li; Xiao Yao; Qi-Jiang Lin; Jing-Wen Yin; Yan Liang; Monika Heiner; Bin Tian; Jingyi Hui; Gang Wang
Journal:  Mol Cell       Date:  2012-01-19       Impact factor: 17.970

5.  Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.

Authors:  Stéphanie Solier; Jennifer Barb; Barry R Zeeberg; Sudhir Varma; Mike C Ryan; Kurt W Kohn; John N Weinstein; Peter J Munson; Yves Pommier
Journal:  Cancer Res       Date:  2010-09-03       Impact factor: 12.701

6.  The eleven-nineteen lysine-rich leukemia gene (ELL2) influences the histone H3 protein modifications accompanying the shift to secretory immunoglobulin heavy chain mRNA production.

Authors:  Christine Milcarek; Michael Albring; Creityeka Langer; Kyung Soo Park
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

7.  Defective histone supply causes changes in RNA polymerase II elongation rate and cotranscriptional pre-mRNA splicing.

Authors:  Silvia Jimeno-González; Laura Payán-Bravo; Ana M Muñoz-Cabello; Macarena Guijo; Gabriel Gutierrez; Félix Prado; José C Reyes
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

8.  Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.

Authors:  Kenneth J Dery; Craig Silver; Lu Yang; John E Shively
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

9.  Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors.

Authors:  Tinghu Zhang; Nicholas Kwiatkowski; Calla M Olson; Sarah E Dixon-Clarke; Brian J Abraham; Ann K Greifenberg; Scott B Ficarro; Jonathan M Elkins; Yanke Liang; Nancy M Hannett; Theresa Manz; Mingfeng Hao; Bartlomiej Bartkowiak; Arno L Greenleaf; Jarrod A Marto; Matthias Geyer; Alex N Bullock; Richard A Young; Nathanael S Gray
Journal:  Nat Chem Biol       Date:  2016-08-29       Impact factor: 15.040

10.  Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data.

Authors:  Nadezhda T Doncheva; John H Morris; Jan Gorodkin; Lars J Jensen
Journal:  J Proteome Res       Date:  2018-12-05       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.